Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert J Ossenkoppele

Showing results (71-80 of 193) with videos related to

Pageof 20
Sort By:
British Journal of Haematology|July 9, 2002
Granulocyte colony-stimulating factor mobilized whole blood containing over 0.3 x 106/kg CD34+ cells is a sufficient graft in autologous transplantation for relapsed non-Hodgkin's lymphomaAndries R Jonkhoff, Arne M De Kreuk, Gaby Franschman, et al.
Haematologica|December 2, 2008
Correlation of minimal residual disease cell frequency with molecular genotype in patients with acute myeloid leukemiaCorine J Hess, Nicole Feller, Fedor Denkers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survivalAnna van Rhenen, Nicole Feller, Angèle Kelder, et al.
Cancer Epidemiology|October 23, 2018
Intensive treatment and trial participation in elderly acute myeloid leukemia patients: A population-based analysis in The NetherlandsBurak Kalin, Esther N Pijnappel, Michel van Gelder, et al.
Cancer Immunology, Immunotherapy : CII|January 4, 2014
Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccinesJurjen M Ruben, Willemijn van den Ancker, Hetty J Bontkes, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 2003
Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemiaTheresia M Westers, Anita G M Stam, Rik J Scheper, et al.
British Journal of Haematology|May 22, 2008
The novel bispecific diabody alphaCD40/alphaCD28 strengthens leukaemic dendritic cell-induced T-cell reactivityIlse Houtenbos, Saskia Santegoets, Theresia M Westers, et al.
Haematologica|May 15, 2003
Differences between the CD34+ and CD34- blast compartments in apoptosis resistance in acute myeloid leukemiaAmber van Stijn, Marjolein A van der Pol, Alice Kok, et al.
Cancers|August 27, 2021
Maturation State-Specific Alternative Splicing in <i>FLT3</i>-ITD and NPM1 Mutated AMLAnna Wojtuszkiewicz, Inge van der Werf, Stephan Hutter, et al.
Plos One|August 8, 2015
A Human Cell Line Model for Interferon-α Driven Dendritic Cell DifferentiationJurjen M Ruben, Lindy L Visser, Kimberley M Heinhuis, et al.
Pageof 20

Showing results (71-80 of 193) with videos related to

Sort By:
Pageof 20
British Journal of Haematology|July 9, 2002
Granulocyte colony-stimulating factor mobilized whole blood containing over 0.3 x 106/kg CD34+ cells is a sufficient graft in autologous transplantation for relapsed non-Hodgkin's lymphomaAndries R Jonkhoff, Arne M De Kreuk, Gaby Franschman, et al.
Haematologica|December 2, 2008
Correlation of minimal residual disease cell frequency with molecular genotype in patients with acute myeloid leukemiaCorine J Hess, Nicole Feller, Fedor Denkers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survivalAnna van Rhenen, Nicole Feller, Angèle Kelder, et al.
Cancer Epidemiology|October 23, 2018
Intensive treatment and trial participation in elderly acute myeloid leukemia patients: A population-based analysis in The NetherlandsBurak Kalin, Esther N Pijnappel, Michel van Gelder, et al.
Cancer Immunology, Immunotherapy : CII|January 4, 2014
Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccinesJurjen M Ruben, Willemijn van den Ancker, Hetty J Bontkes, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 2003
Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemiaTheresia M Westers, Anita G M Stam, Rik J Scheper, et al.
British Journal of Haematology|May 22, 2008
The novel bispecific diabody alphaCD40/alphaCD28 strengthens leukaemic dendritic cell-induced T-cell reactivityIlse Houtenbos, Saskia Santegoets, Theresia M Westers, et al.
Haematologica|May 15, 2003
Differences between the CD34+ and CD34- blast compartments in apoptosis resistance in acute myeloid leukemiaAmber van Stijn, Marjolein A van der Pol, Alice Kok, et al.
Cancers|August 27, 2021
Maturation State-Specific Alternative Splicing in <i>FLT3</i>-ITD and NPM1 Mutated AMLAnna Wojtuszkiewicz, Inge van der Werf, Stephan Hutter, et al.
Plos One|August 8, 2015
A Human Cell Line Model for Interferon-α Driven Dendritic Cell DifferentiationJurjen M Ruben, Lindy L Visser, Kimberley M Heinhuis, et al.
Pageof 20